Clinical trial
Efficacy and Safety of Thalidomide in Treating Pediatric PFAPA Syndrome: A Multicenter Randomized Controlled Trial
NCT07476625 is registered in ClinicalTrials.gov with Wenjie Zheng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Thalidomide in Treating Pediatric PFAPA Syndrome: A Multicenter Randomized Controlled Trial
- Lead sponsor
- Wenjie Zheng
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- March 30, 2028
- Enrollment
- 106 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome